Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Pharmaindustrie / Medikamente
  • Allergien
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bosnien-Herzegowina
  • Dänemark
  • Deutschland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Italien
  • Kroatien
  • Litauen
  • Mazedonien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Serbien
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vereinigtes Königreich
  • Asien / Pazifik
  • China
  • Hong Kong
  • Indonesien
  • Japan
  • Malaysia
  • Neuseeland
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Usbekistan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Algerien
  • Iran
  • Israel
  • Kamerun
  • Kenia
  • Marokko
  • Nigeria
  • Saudi Arabien
  • South Africa
  • Tunesien
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Bolivien
  • Brasilien
  • Chile
  • Costa Rica
  • Kolumbien
  • Mexiko
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • Datamonitor
  • Euromonitor
  • Global Markets Direct
  • GlobalData
  • Life Science Analytics
  • Filter zurücksetzen
Sprache
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • Filter zurücksetzen
laedt

Marktanalyse - Cough, Cold and Allergy (hay Fever) Remedies - South Africa

Market Direction
Euromonitor

Euromonitor

7 / 2010
40 Seiten
Typ: Marktanalyse
Sprache: Englisch
Regionen: South Africa
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

675,00 €*
PDF-Datei per E-Mail , versandkostenfrei


An outbreak of the H1N1 (swine flu) raised the concerns of many consumers. South Africa had no choice but to develop its own flu vaccine to combat the virus, as first world countries opted to cover their own populations before making the vaccine available to the developing world. Approximately 5,000 cases were reported in South Africa and 15 people died from it. In anticipation, consumers used OTC products in an attempt to alleviate cold and flu symptoms.

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies Products in South Africa report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Child-Specific Cough, Cold and Allergy Remedies, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Cough, Cold and Allergy (hay Fever) Remedies in South Africa

Euromonitor International

July 2010

List of Contents and Tables

Executive Summary

Steady Growth in Challenging Retail Environment

Self-medication Plays Major Role in Volume Sales

OTC Sales Dominated by A Small Number of Players

Grocery Channels Increase Footprint

Health Concerns at the Forefront of Consumers' Minds

Key Trends and Developments

In-store Pharmacies Expand Footprint

Recession Forces Companies To Increase Their Advertising Campaigns

Increased Self-medication Expands Untrustworthy Trade Footprint

Hiv/aids Symptoms and Side-effects Elevate OTC Sales

Growing Appeal for Natural/herbal Variants

Market Indicators

Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009

Table 2 Life Expectancy at Birth 2004-2009

Market Data

Table 3 Sales of Consumer Health by Sector: Value 2004-2009

Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009

Table 5 Consumer Health Company Shares by Value 2005-2009

Table 6 Consumer Health Brand Shares by Value 2006-2009

Table 7 Penetration of Private Label by Sector 2004-2009

Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009

Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009

Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014

Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication and Preventative Medicine

Generics

Switches

Summary 1 Consumer Health Switches in 2009

Definitions

Sector and Subsector Definitions

Summary 2 Research Sources

Adcock Ingram Ltd

Strategic Direction

Key Facts

Summary 3 Adcock Ingram Ltd: Key Facts

Summary 4 Adcock Ingram Ltd: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 5 Adcock Ingram Ltd: Competitive Position 2009

Aspen Pharmacare (pty) Ltd

Strategic Direction

Key Facts

Summary 6 Aspen Pharmacare (Pty) Ltd: Key Facts

Summary 7 Aspen Pharmacare (Pty) Ltd - SA Pharmaceutical Division: Operational Indicators2

Company Background

Production

Competitive Positioning

Summary 8 Aspen Pharmacare: Competitive Position 2009

Bioscience Brands Ltd

Strategic Direction

Key Facts

Summary 9 Bioscience Ltd: Key Facts

Summary 10 Bioscience Ltd: Number of employees

Company Background

Production

Competitive Positioning

Summary 11 Bioscience Brands (Pty) Ltd: Competitive Position 2009

Cipla-medpro (pty) Ltd

Strategic Direction

Key Facts

Summary 12 Cipla-Medpro (Pty) Ltd: Key Facts

Summary 13 Cipla-Medpro (Pty) Ltd Limited: Operational Indicators

Company Background

Production

Competitive Positioning

Dischem (pty) Ltd

Strategic Direction

Key Facts

Summary 14 Dis-Chem (Pty) Ltd: Key Facts

Company Background

Production

Competitive Positioning

Novartis South Africa (pty) Ltd

Strategic Direction

Key Facts

Summary 15 Novartis South Africa (Pty) Ltd: Key Facts

Company Background

Production

Competitive Positioning

Summary 16 Novartis South Africa (Pty) Ltd: Competitive Position 2009

Vital Health Foods (pty) Ltd

Strategic Direction

Key Facts

Summary 17 Vital Health Foods (Pty) Ltd: Key Facts

Company Background

Competitive Positioning

Summary 18 Vital Health Foods (Pty) Ltd: Competitive Position 2009

Headlines

Trends

Switches

Competitive Landscape

Prospects

Category Data

Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2004-2009

Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2004-2009

Table 14 Sales of Decongestants by Type: Value 2004-2009

Table 15 Sales of Decongestants by Type: % Value Growth 2004-2009

Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2004-2009

Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2004-2009

Table 18 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2005-2009

Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2006-2009

Table 20 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2009-2014

Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2009-2014

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: